LeMaitre Vascular(US:LMAT)2025-02-27 21:40Financial Performance - Q4 2024 sales reached $55.7 million, representing a 14% increase compared to Q4 2023, with organic growth also at 14%[10] - Operating income for Q4 2024 was $12.9 million, a 26% increase year-over-year, with operating margin at 23%[10] - The company reported net income of $11.2 million for Q4 2024, up 32% from $8.5 million in Q4 2023, resulting in diluted earnings per share of $0.49, a 30% increase[21] - For the three months ended December 31, 2024, total net sales reached $55,717, a 14% increase from $48,883 in the same period of 2023[22] - EBITDA for the three months ended December 31, 2024, was $15,032, representing an 18% increase from $12,764 in the same period of 2023[23] - For the year ended December 31, 2024, total net sales were $219,863, up from $193,484 in 2023[22] - The company’s EBITDA for the year ended December 31, 2024, was $61,739, a 34% increase from $45,913 in 2023[23] Sales Guidance - The company provided Q1 2025 sales guidance of $56.7 million to $58.7 million, reflecting an 8% increase year-over-year[6] - Full-year 2025 sales guidance is set at $235.4 million to $242.8 million, indicating a 9% increase compared to 2024[6] - Adjusted projected net sales for the three months ending March 31, 2025, are estimated at $58,695, reflecting a 10% increase from the prior year[24] - Adjusted projected net sales increase for the year ending December 31, 2025, is expected to be $21,900, or 10% growth[24] Dividend and Shareholder Returns - The company announced a quarterly dividend increase to $0.20 per share, a 25% rise, to be paid on March 27, 2025[7] - A share repurchase program was authorized for up to $75 million, set to conclude on February 17, 2026[9] Cash and Financing - Cash and cash equivalents increased to $299.7 million, up $175.8 million sequentially[10] - The company issued $172.5 million in 2.50% Convertible Senior Notes due 2030, with net proceeds allocated for working capital and business development[8] Regional Sales Performance - Net sales in the Americas for the three months ended December 31, 2024, were $36,629, accounting for 66% of total net sales, compared to $32,812 and 67% in the prior year[22] - Net sales in Europe, Middle East, and Africa for the three months ended December 31, 2024, were $15,275, representing 27% of total net sales[22] Currency Impact - The impact of currency exchange rate fluctuations added $95 to net sales for the three months ended December 31, 2024[24] Gross Margin - Gross margin improved to 69.3%, up 121 basis points from Q4 2023, driven by higher average selling prices and manufacturing efficiencies[5]